Travere Therapeutics (TVTX)
Nasdaq • TVTX • US89422G1076
ORTEX Data Highlights
ORTEX Data Highlights
As of Nov 3, 2026, ORTEX estimates 11.5% of free float is sold short, 4.6 days to cover, cost to borrow 0.45%.
Market Cap
5.03b USD | # 2589 in US
Volume
1.92m shares | 113.76m USD
Shares Outstanding
95.99m
Free Float Shares
98.92% | 94.95m
